Proton Pump Inhibitor Use Associated With Increased Asthma Risk

Abstract

Research Article| May 01 2021 Proton Pump Inhibitor Use Associated With Increased Asthma Risk AAP Grand Rounds (2021) 45 (5): 52. https://doi.org/10.1542/gr.45-5-52 Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Twitter LinkedIn Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Proton Pump Inhibitor Use Associated With Increased Asthma Risk. AAP Grand Rounds May 2021; 45 (5): 52. https://doi.org/10.1542/gr.45-5-52 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search nav search search input Search input auto suggest search filter All PublicationsAll JournalsAAP Grand RoundsPediatricsHospital PediatricsPediatrics In ReviewNeoReviewsAAP NewsAll AAP Sites Search Advanced Search Topics: asthma, proton pump inhibitors Source: Wang YH, Wintzell V, Ludvigsson JF, et al. Association between proton pump inhibitor use and risk of asthma in children [published online ahead of print February 8, 2021]. JAMA Pediatr. 2021. doi: https://doi.org/10.1001/jamapediatrics.2020.5710Google Scholar Investigators from Karolinska Institutet, Stockholm, Sweden, conducted a retrospective cohort study to assess the association between proton pump inhibitor (PPI) use and asthma in children. For the study, the investigators linked data from several national Swedish registries that included health care use, diagnoses, drug prescriptions, and demographic information on all citizens. Swedish children who were <18 years old at some point between January 2007 and June 2016 were eligible for inclusion in the study. Those who initiated PPI use during the study period, with no record of a PPI prescription in the prior year, constituted 1 cohort. Children with a history of asthma prior to initiation of... You do not currently have access to this content.